Research News and Research

RSS

Physical activity can positively affect cells in intervertebral discs

Physical exercise has a positive effect on the formation of cells in the intervertebral discs. This is shown by a study from the Sahlgrenska Academy, University of Gothenburg, presented at the annual meeting of the International Society for the Study of the Lumbar Spine (ISSLS), which is currently taking place in Gothenburg.

29 Jun 2011

Genetic tools that enable cell type-specific delivery hold promise for combating incurable neurologic diseases

Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. Five of the most exciting developments in this rapidly advancing field are presented in a series of articles in the June issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc..

29 Jun 2011

Christie poised to sign bill that will increase costs of benefits for state employees

The New Jersey state Senate on Monday approved the bill, which will raise pension and health benefit expenses for more than 500,000 state workers. Meanwhile, in Illinois, Gov. Pat Quinn will sign today a measure to overhaul the state's workers' compensation system.

29 Jun 2011

Global economic recession ends concerted rise in fertility rates

The global economic recession of 2008-09 has been followed by a decline in fertility rates in Europe and the United States, bringing to an end the first concerted rise in fertility rates in the developed world since the 1960s, according to research published today.

29 Jun 2011

Roundup: UMass students complain about insurance plan; Indiana stops paying for children's vaccines; Suit filed to stop Arizona Medicaid cuts

Student leaders at the University of Massachusetts Amherst campus say changes in the students' health insurance plan will unfairly hit hardest on women, low-income students, and those with mental illnesses.

29 Jun 2011

U.Va. and Epsilon partner to provide commercial version of computer-based diabetes simulation tool

A computer-based diabetes simulation tool developed by University of Virginia researchers is now commercially available, thanks to a partnership with the Charlottesville-based medical research firm The Epsilon Group. The simulator is the only protocol that has been accepted by the U.S. Food and Drug Administration as an alternative to animal testing of Type 1 diabetes control strategies.

29 Jun 2011

Viewpoints: A health law legal precedent, hospital-acquired infections, price cap scrutiny

The Supreme Court's most important ruling this year may have been its unanimous decision in Bond v. United States, which held that individual citizens can challenge federal statutes when they encroach on authority the Constitution reserves to the states. The decision, authored by Justice Anthony Kennedy, has far-reaching implications — especially for the government's efforts to defend ObamaCare.

29 Jun 2011

FDA clears Nuvo's IND for Lidocaine Spray formulation

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.

29 Jun 2011

Expert addresses need to improve risk stratification of heart failure patients eligible for ICD or CRT-D

Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.

28 Jun 2011

IOTA NanoSolutions secures funding for commercialisation of ContraSol technology

IOTA NanoSolutions Limited, a specialist formulation company, is pleased to announce today that it has completed a financing round to support the commercialisation of its proprietary nanodispersion formation technology, ContraSol™. New investor, QIB(UK) Plc joins Unilever Ventures Limited (UV) in this financing round.

28 Jun 2011

Conventional Estrogen Receptor measurement methods may result in 10-20% false negative rate

A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology.

28 Jun 2011

New insights into 'sundowning' syndrome

New research provides the best evidence to date that the late-day anxiety and agitation sometimes seen in older institutionalized adults, especially those with dementia, has a biological basis in the brain.

28 Jun 2011

AMRI, Proteros ink new partnership

AMRI and Proteros Biostructures GmbH announced today that they have signed an agreement for a joint offering to the life sciences industry. Proteros, an expert in the field of protein crystallization and X-ray structural analysis, provides services that complement AMRI's existing drug discovery capabilities in chemistry, in vitro biology, drug metabolism and pharmacokinetics services.

28 Jun 2011

Federal Ministry of Health supports radionuclide production at Research Neutron Source

The German Federal Ministry of Health has awarded more than one million euros in research and development funding for the efficient production of an important cancer diagnostic agent at the research neutron source FRM II. In a 2009 feasibility study, the Technische Universitaet Muenchen demonstrated that due to the high neutron flux the neutron source in Garching can produce about half of the European demand of the radioisotope molybdenum-99.

28 Jun 2011

Protein c-JUN protects both tumour accelerating gene and tumour suppressor gene

The process of cell division is tightly regulated, as mistakes may lead to cancer. The so-called c-JUN protein has been fingered as causing tumours in both skin and liver. It has long been known to have a direct role in reducing the expression of a gene (p53) that leads to the death of abnormal cells and to activate transcription of a further gene (CyclinD1) that directly promotes cell division.

28 Jun 2011

First Edition: June 28, 2011

Today's headlines include reports from the states about action on public employee benefit reforms and Planned Parenthood funding.

28 Jun 2011

RCSI researchers identify novel drug target for osteomyeltitis

New research from the Royal College of Surgeons in Ireland (RCSI) has identified a novel drug target for the treatment of infection in bone.

28 Jun 2011

Drug labels sometimes lack key safety warnings: Consumer Reports Health

It's comparable to driving a car without a seatbelt—a new investigation from Consumer Reports Health finds that drug labels sometimes lack key safety warnings and some pharmacies fail to include the medication guides required by the federal government.

28 Jun 2011

Global food insecurity could become a 'permanent disaster,' Annan says

Global food insecurity that has left almost one billion people hungry could become a "permanent disaster" and endanger millions of lives, former U.N. secretary-general Kofi Annan said, Bloomberg reports.

28 Jun 2011

Three research organisations to support open-access journal for biomedical, life sciences

The Howard Hughes Medical Institute, the Max Planck Society and the Wellcome Trust announced today that they are to support a new, top-tier, open access journal for biomedical and life sciences research.

28 Jun 2011

Research News and Research

Physical activity can positively affect cells in intervertebral discs

Genetic tools that enable cell type-specific delivery hold promise for combating incurable neurologic diseases

Christie poised to sign bill that will increase costs of benefits for state employees

Global economic recession ends concerted rise in fertility rates

Roundup: UMass students complain about insurance plan; Indiana stops paying for children's vaccines; Suit filed to stop Arizona Medicaid cuts

U.Va. and Epsilon partner to provide commercial version of computer-based diabetes simulation tool

Viewpoints: A health law legal precedent, hospital-acquired infections, price cap scrutiny

FDA clears Nuvo's IND for Lidocaine Spray formulation

Expert addresses need to improve risk stratification of heart failure patients eligible for ICD or CRT-D

IOTA NanoSolutions secures funding for commercialisation of ContraSol technology

Conventional Estrogen Receptor measurement methods may result in 10-20% false negative rate

New insights into 'sundowning' syndrome

AMRI, Proteros ink new partnership

Federal Ministry of Health supports radionuclide production at Research Neutron Source

Protein c-JUN protects both tumour accelerating gene and tumour suppressor gene

First Edition: June 28, 2011

RCSI researchers identify novel drug target for osteomyeltitis

Drug labels sometimes lack key safety warnings: Consumer Reports Health

Global food insecurity could become a 'permanent disaster,' Annan says

Three research organisations to support open-access journal for biomedical, life sciences

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Event guide: 2nd World RNA-Based Therapeutics & Vaccines Summit Korea

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance